PORTAGE, Mich., March 4, 2025 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, announced the launch of its Steri-Shield 8 personal protection system, the latest in its personal protective equipment (PPE). Steri-Shield 8 was designed through years of research, testing and collaboration with real-world users.
"Over the last 30 years, we have relentlessly innovated our personal protection system to address the needs of today's professionals and prioritize the safety and well-being of care team members and patients," said Bill Scott, vice president and general manager of Stryker's Orthopaedic Instruments business. "As the personal protection system leader in the market, we're pleased to introduce the Steri-Shield 8 system to further enhance protection and wearability."
The Steri-Shield 8 personal protection system includes a helmet with three points of contact for a customizable fit, a sleeker battery, a more efficient charging station and three toga styles.
Key features include:
For more information, visit: https://www.stryker.com/us/en/orthopaedic-instruments/products/steri-shield-8.html
About Stryker
Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com.
*Stryker internal data
Media Contact:
Beth Sizemore
Sr. Director, Strategic Communications, Instruments
This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$394.00 |
Daily Change: | 2.19 0.56 |
Daily Volume: | 214,639 |
Market Cap: | US$150.200B |
May 01, 2025 |
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MOREClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREEnd of content
No more pages to load